Modification and Implementation of NCCN Guidelines™ on Prostate Cancer in the Middle East and North Africa Region

Restricted access

A prostate cancer committee was established to modify the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) on Prostate Cancer for adaptation and implementation in the Middle East and North Africa (MENA) region. The objective was to enhance the multidisciplinary approach to the treatment of prostate cancer. The committee, comprising regional experts in the fields of urologic, medical, and radiation oncology, reviewed the 2009 version of the NCCN Guidelines on Prostate Cancer and suggested modifications based on the unique needs of the regions determined through published evidence and local expertise. The committee identified several areas in the NCCN Guidelines that they believed required modification, which are presented in this article. The treatment of prostate cancer in the MENA region has numerous challenges. The hope is that this effort to modify the NCCN Guidelines on Prostate Cancer for practical use in the MENA region will improve regional awareness and patient care.

Correspondence: Waleed A. Hassen, MD, Department of Urology, Tawam Hospital, P.O. Box 15258, Al Ain, United Arab Emirates. E-mail:
  • 1.

    JemalASiegelRWardE. Cancer statistics, 2009. CA Cancer J Clin2009;59:225249.

  • 2.

    ParkinDMBrayFFerlayJPisaniP. Global Cancer Statistics, 2002. CA Cancer J Clin2005;55:74108.

  • 3.

    YoungJL. Cancer incidence in the Middle East and Gulf Cooperation Council countries. Presented at the Middle East Cancer Consortium Steering Committee Meeting; January 20 2003; Lyon France.

    • Search Google Scholar
    • Export Citation
  • 4.

    ShamseddineASibaiAMGehchanN. Cancer incidence in postwar Lebanon: findings from the first national population-based registry, 1998. Ann Epidemiol2004;14:663668.

    • Search Google Scholar
    • Export Citation
  • 5.

    Unicef Regional Statistics2009.

  • 6.

    BiancoFJJrRiedelERBeggCB. Variations among high volume surgeons in the rate of complications after radical prostatectomy: further evidence that technique matters. J Urol2005;173:20992103.

    • Search Google Scholar
    • Export Citation
  • 7.

    International Atomic Energy Agency. Directory of Radiotherapy Centres. Available at: Accessed March 31 2010.

    • Search Google Scholar
    • Export Citation
  • 8.

    SmithDCRedmanBGFlahertyLE. A phase II trial of oral diethylstilbesterol as a second-line hormonal agent in advanced prostate cancer. Urology1998;52:257260.

    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 264 238 21
PDF Downloads 24 22 2
EPUB Downloads 0 0 0